Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-25-000711
Filing Date
2025-07-30
Accepted
2025-07-30 21:28:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 27832
2 JOINT FILING AGREEMENT ss5146654_ex9901.htm EX-99.1 6440
  Complete submission text file 0000947871-25-000711.txt   36035
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SCHEDULE 13D/A

Mailing Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130
Business Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130 857-343-8292
ImageneBio, Inc. (Subject) CIK: 0001835579 (see all company filings)

EIN.: 811697316 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92449 | Film No.: 251168990
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)